Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
RecruitingNCT07118956Phase: NAStarted 2025-05-01
Summary
The goal of this clinical trial is to learn whether 100HZ respiratory-gated vagus nerve stimulation (RAVANS) can improve the non-motor symptoms in people with Parkinson's disease (PD). It will also le
Eligibility
Sex
ALL
Min Age
40 Years
Max Age
90 Years
Locations
Cognitive Neuropsychology Lab Anhui Medical UniversityHefei, Anhui, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07118956